Vestal Point Capital, LP Insmed Inc Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Insmed Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 900,000 shares of INSM stock, worth $69.8 Million. This represents 3.68% of its overall portfolio holdings.
Number of Shares
900,000
Previous 1,600,000
43.75%
Holding current value
$69.8 Million
Previous $117 Billion
46.8%
% of portfolio
3.68%
Previous 8.86%
Shares
4 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$985 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$552 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...